THE HEALTH EQUITY STRATEGIES GROUP, LLC

Registrant on federal lobbying filings · filed 2025 to 2026

$96,000 Income reported

1 Clients represented

6 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. Everything on this page is grouped by the registrant's LDA id (401106284), not by name.

Clients 1

TRAVERE THERAPEUTICS $96,000 6 filings

Reported by year 2 years

2026 $32,000 2 filings
2025 $64,000 4 filings

Issues lobbied 4

Health Issues 6
Medical/Disease Research/Clinical Labs 6
Medicare/Medicaid 6
Pharmacy 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 6
SENATE 1

Recent filings 6 total

Q2

TRAVERE THERAPEUTICS

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $16,000 income · posted Aug 4, 2026

View → Q1

TRAVERE THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2026 · House · $16,000 income · posted May 19, 2026

View → Q4

TRAVERE THERAPEUTICS

4th Quarter (Oct 1 - Dec 31) 2025 · House · $16,000 income · posted Feb 20, 2026

View → Q3

TRAVERE THERAPEUTICS

3rd Quarter (July 1 - Sep 30) 2025 · House · $16,000 income · posted Nov 20, 2025

View → Q2

TRAVERE THERAPEUTICS

2nd Quarter (Apr 1 - June 30) 2025 · House · $16,000 income · posted Aug 20, 2025

View → Q1

TRAVERE THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2025 · House · $16,000 income · posted May 6, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.